These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33635913)
1. Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria. Wagai JN; Rhoda D; Prier M; Trimmer MK; Clary CB; Oteri J; Okposen B; Adeniran A; Danovaro-Holliday C; Cutts F PLoS One; 2021; 16(2):e0247415. PubMed ID: 33635913 [TBL] [Abstract][Full Text] [Related]
2. Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys. Utazi CE; Wagai J; Pannell O; Cutts FT; Rhoda DA; Ferrari MJ; Dieng B; Oteri J; Danovaro-Holliday MC; Adeniran A; Tatem AJ Vaccine; 2020 Mar; 38(14):3062-3071. PubMed ID: 32122718 [TBL] [Abstract][Full Text] [Related]
3. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016. Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975 [TBL] [Abstract][Full Text] [Related]
4. Impact of measles supplementary immunization activities on reaching children missed by routine programs. Portnoy A; Jit M; Helleringer S; Verguet S Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680 [TBL] [Abstract][Full Text] [Related]
5. Descriptive study of measles vaccination second dose reporting and barriers to improving coverage in six districts in Malawi. Chirwa G; Wilkins KA; Mercer DJ Pan Afr Med J; 2020; 35(Suppl 1):5. PubMed ID: 32373256 [TBL] [Abstract][Full Text] [Related]
6. Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach. Campbell JD; Pasetti MF; Oot L; Adam Z; Tefera M; Beyane B; Mulholland N; Steinglass R; Krey R; Chen WH; Blackwelder WC; Levine MM Vaccine; 2021 Sep; 39(40):5802-5813. PubMed ID: 34465472 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China. Hu Y; Chen Y; Wang Y; Liang H Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094 [TBL] [Abstract][Full Text] [Related]
10. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria. Utazi CE; Aheto JMK; Wigley A; Tejedor-Garavito N; Bonnie A; Nnanatu CC; Wagai J; Williams C; Setayesh H; Tatem AJ; Cutts FT Vaccine; 2023 Jan; 41(1):170-181. PubMed ID: 36414476 [TBL] [Abstract][Full Text] [Related]
11. Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign. Mogekwu FI; Oteri JA; Nsubuga P; Ezebilo O; Maxwell N; Wiwa O; Braka F; Shuaib F Vaccine; 2021 Nov; 39 Suppl 3():C38-C45. PubMed ID: 33461831 [TBL] [Abstract][Full Text] [Related]
13. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009. Pezzoli L; Conteh I; Kamara W; Gacic-Dobo M; Ronveaux O; Perea WA; Lewis RF BMC Public Health; 2012 Jun; 12():415. PubMed ID: 22676225 [TBL] [Abstract][Full Text] [Related]
14. Determinants of vaccine coverage and timeliness in a northern Pakistani village. Jamison AF; McCormick BJJ; Hussain E; Thomas ED; Azam SI; Hansen CL; Rasmussen ZA PLoS One; 2022; 17(2):e0263712. PubMed ID: 35176050 [TBL] [Abstract][Full Text] [Related]
15. Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018. Jean Baptiste AE; Masresha B; Wagai J; Luce R; Oteri J; Dieng B; Bawa S; Ikeonu OC; Chukwuji M; Braka F; Sanders EAM; Hahné S; Hak E Vaccine; 2021 Nov; 39 Suppl 3():C89-C95. PubMed ID: 33875267 [TBL] [Abstract][Full Text] [Related]
16. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria. Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790 [TBL] [Abstract][Full Text] [Related]
17. High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries. Utazi CE; Thorley J; Alegana VA; Ferrari MJ; Takahashi S; Metcalf CJE; Lessler J; Tatem AJ Vaccine; 2018 Mar; 36(12):1583-1591. PubMed ID: 29454519 [TBL] [Abstract][Full Text] [Related]
18. Using Household Surveys to Assess Missed Opportunities for Simultaneous Vaccination: Longitudinal Examples from Colombia and Nigeria. Rhoda DA; Prier ML; Clary CB; Trimner MK; Velandia-Gonzalez M; Danovaro-Holliday MC; Cutts FT Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358211 [TBL] [Abstract][Full Text] [Related]
19. How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from Nigeria. Sato R Hum Vaccin Immunother; 2024 Dec; 20(1):2355036. PubMed ID: 38783606 [TBL] [Abstract][Full Text] [Related]
20. Measles-rubella mass immunization campaign in Albania, November 2000. Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]